search
Highlights
     // . //  Oliver Wyman Health //  Video: Aetna's Shift to a Consumer Health Services Company

    Video: Aetna's Shift to a Consumer Health Services Company

    Image

    Aetna's mission to bring healthcare services to the whole person.

    Brigitte Nettesheim

    2 min read

    Table of Contents

      Editor's Note: What's the future of the CVS-Aetna merger? At the 2019 Oliver Wyman Health Innovation Summit, Aetna's Brigitte Nettesheim shared her thoughts on this and more with former MedCity News reporter, Kevin Truong. Brigitte shares Aetna's perspective on network design, joint ventures, trust-powered relationships, and the importance of community networks.

      Memorable Moments:

      • "At Aetna, we've been on a journey to transform ourselves from a traditional health insurance company into a consumer services company, delivering consumers services that pertain to their health. This allows us by collaborating and combining with CVS to bring all of our expertise and insights combined to work on behalf of delivering those services to consumers."
      • "We have to think about mental well-being and also social well-being. It's the whole person we're trying to bring services to. It's coordinating services and access to services that aren't necessarily covered by the traditional healthcare system."
      • "Traditionally, payers and providers have been at odds. One's revenue is one's cost. And that's just a tough economic model overall. So, the question is, how do we learn about each other's businesses in-depth and understand what our common objectives are?"
      Author
      • Brigitte Nettesheim

      Looking Back to Look Ahead: Predictions on Healthcare’s Future

      Here's what executives at Mount Sinai Health System, BCBS of Michigan, and Optum had to say about the future of healthcare at the last Oliver Wyman Health Innovation Summit.

      Day Three Summit Speakers Talk Millennials, Physician Education, and Population Health

      What some of healthcare’s most influential voices had to say about the past, present, and future of the industry on the Summit's final day.

      Measuring The Value Of A Drug

      As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.

      Special Series: The Future of ACA Exchanges: Making History or Repeating It?

      Recent exits indicate a fundamental miscalculation of the profile of the enrollees in the individual market. What’s next for the Exchanges?